Clinical trial

Comparison of Treatment Simplification by LPV/r vs Current Treatment…

NCT00140751 · Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba, Other · Completed

Key facts

NCT number NCT00140751
Title Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients
Official title A 48-Weeks National Multicenter Randomized Open Clinical Trial Evaluating Tolerance and Efficacy of a Treatment Simplification by Lopinavir/Ritonavir Versus Continuation of Current Treatment in HIV-Infected Patients With a Viral Load Inferior to 50 Copies/mL Since 6 Months At Least
Acronym KALESOLO
Lead sponsor Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba, Other
Collaborators Abbott Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions HIV Infections
Intervention type Drug
Interventions Lopinavir/ritonavir (drug)
Enrollment 186
Start date Oct 1, 2005
Primary completion Jan 1, 2008
Completion Jan 1, 2008
First posted Sep 1, 2005
Last update posted Sep 19, 2013
Countries France

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies